Auro Vaccines LLC

Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary technology platform that allows us to quantitatively and qualitatively tailor effective immune responses to specific targets. The Prime/Boost System of Vaccines (PBS Vax) platform provides the ability to “tune” the immune response to whatever is required for a specific target and disease context. The exceptional flexibility of this platform overcomes the shortcomings of current DNA and classic prophylactic vaccines, enabling us to address targets of high unmet medical need. Auro Vaccines has an experienced vaccine development team with proven skills to execute the company’s commercial vision of creating new vaccines that will make a significant impact on the health of patients worldwide.